Literature DB >> 16781104

Post-mortem toxicology.

Olaf H Drummer1.   

Abstract

Studies examining post-mortem processes are difficult to conduct since changes will have already occurred when the body arrives at the mortuary. While control of collection site for blood can minimize changes in concentration it is very difficult to conduct experiments in humans aimed at understanding the mechanisms and determining the extent of such changes. The use of appropriate animal models can be useful in this regard providing the species and conditions are carefully chosen. Pharmacokinetic studies in humans are also very useful for understanding the changes in drug concentration with time in blood (and other fluids) and also for improving our understanding of drug effects. Unfortunately, doses of illicit drugs that can be given are relatively low to guarantee safety hence extrapolations are made to real life situations. Individual case studies can be useful to describe an unusual or particularly interesting circumstances but little useful information can be obtained when trying to ascertain the role of competing factors, e.g. role of individual drugs when multiple drugs are present, varying toxicity between route of administration, and the role of age or natural disease when drugs are also present. Epidemiological approaches by reviewing large numbers of related cases are the most powerful tool to obtain this information. All of these studies need to operate under the ethical and legal framework appropriate for a jurisdiction. This paper discusses the relative merits of scientific approaches to research in post-mortem toxicology and provides guidance on the most appropriate techniques for future studies.

Entities:  

Mesh:

Year:  2006        PMID: 16781104     DOI: 10.1016/j.forsciint.2006.05.020

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  12 in total

Review 1.  Post-mortem clinical pharmacology.

Authors:  R E Ferner
Journal:  Br J Clin Pharmacol       Date:  2008-05-29       Impact factor: 4.335

2.  The effect of the postmortem interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens.

Authors:  Dimitri Gerostamoulos; Jochen Beyer; Voula Staikos; Penny Tayler; Noel Woodford; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2012-05-22       Impact factor: 2.007

Review 3.  The influence of putrefaction and sample storage on post-mortem toxicology results.

Authors:  Danielle M Butzbach
Journal:  Forensic Sci Med Pathol       Date:  2009-11-28       Impact factor: 2.007

Review 4.  Back to the Future - Part 2. Post-mortem assessment and evolutionary role of the bio-medicolegal sciences.

Authors:  Santo Davide Ferrara; Giovanni Cecchetto; Rossana Cecchi; Donata Favretto; Silke Grabherr; Takaki Ishikawa; Toshikazu Kondo; Massimo Montisci; Heidi Pfeiffer; Maurizio Rippa Bonati; Dina Shokry; Marielle Vennemann; Thomas Bajanowski
Journal:  Int J Legal Med       Date:  2017-04-25       Impact factor: 2.686

5.  Post mortem toxicology in the elderly.

Authors:  Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2012-12-07       Impact factor: 2.007

6.  The postmortem redistribution of iso-α-acids in postmortem specimens.

Authors:  Luke N Rodda; Dimitri Gerostamoulos; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2014-10-16       Impact factor: 2.007

7.  Deaths involving contraindicated and inappropriate combinations of serotonergic drugs.

Authors:  Jennifer L Pilgrim; Dimitri Gerostamoulos; Olaf H Drummer
Journal:  Int J Legal Med       Date:  2010-12-01       Impact factor: 2.686

8.  The role of toxicology interpretations in prevention of sudden death.

Authors:  Jennifer L Pilgrim; Dimitri Gerostamoulos; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2012-01-08       Impact factor: 2.007

9.  Preliminary results on the postmortem measurement of 3-beta-hydroxybutyrate in liver homogenates.

Authors:  Cristian Palmiere; Patrice Mangin; Dominique Werner
Journal:  Int J Legal Med       Date:  2013-05-31       Impact factor: 2.686

10.  ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram.

Authors:  L Karlsson; H Green; A L Zackrisson; F Bengtsson; I Jakobsen Falk; B Carlsson; J Ahlner; F C Kugelberg
Journal:  Int J Legal Med       Date:  2013-03-21       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.